Institutional members access full text with Ovid®

Share this article on:

Communicating the Risks of Medicines: Time to Move Forward

Dal Pan, Gerald J. MD, MHS

doi: 10.1097/MLR.0b013e31825852f0
Editorial

Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD

The views expressed are those of the author and not necessarily those of the US Food and Drug Administration of the US Government.

The author declares no conflict of interest.

Reprints: Gerald J. Dal Pan, MD, MHS, Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 20993. E-mail: gerald.dalpan@fda.hhs.gov.

© 2012 Lippincott Williams & Wilkins, Inc.